NEKTAR
Live / Applied — Fourth extension granted (statement of use) (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 20 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97725910
- Mark type
- Word mark
- Filed
- 20 Dec 2022
- Published for opposition
- 07 Nov 2023
- Attorney of record
- Jennifer D. Arkowitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the treatment of medical conditions in the nature of cancer; pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the treatment of medical conditions in the nature of immune system related diseases and disorders
Owner
- Nektar Therapeutics, San Francisco, CA, US
- Nektar Therapeutics, San Francisco, CA, US
Prosecution history
- 05 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2025 — SOU EXTENSION 4 GRANTED
- 04 Nov 2025 — SOU EXTENSION 4 FILED
- 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 3 GRANTED
- 01 May 2025 — SOU EXTENSION 3 FILED
- 01 May 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jan 2025 — SOU EXTENSION 2 GRANTED
- 10 Dec 2024 — SOU EXTENSION 2 FILED
- 10 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jun 2024 — SOU EXTENSION 1 GRANTED
- 29 Jun 2024 — SOU EXTENSION 1 FILED